We’re engaging practices as part of new diabetes prevention study

CLAHRC Greater Manchester is working with HitachiSalford Royal NHS Foundation TrustNHS Salford Clinical Commissioning Group and NorthWest EHealth to engage with practices across Salford.

This work follows on from the impaired glucose tolerance (IGT) and impaired glucose regulation (IGR) care call studies delivered by CLAHRC GM in conjunction with the Salford Diabetes team. Both were evaluated and produced statistically significant results demonstrating the effectiveness of telephone-based lifestyle interventions with people at risk of developing type 2 diabetes.

Hitachi diabetes 270515 small
The Care Call system helps those at risk of developing diabetes to maintain a healthier lifestyle, including eating healthy foods.

In a natural progression, this work will make use of online technology, allowing patients to fill out a self-assessment questionnaire ahead of their care call action-planning call. This in turn will help healthcare professionals to provide tailored advice (enriched by the information they receive before action-planning takes place), and will also allow patients to monitor their progress while on the go.

The trial – named Comparison of Active Treatments For Impaired Glucose Regulation (CATFISH) – will compare an enhanced IGR care call service against the existing care call service to establish the acceptability, effectiveness and efficiency of the enhanced service. Both the telephone and web-based intervention will support people who are at the greatest risk of developing type 2 diabetes to work towards healthy lifestyle goals, reducing their risk of developing diabetes, improving their health overall, and reducing their risk of developing cardiovascular disease.

CLAHRC GM has a key role to play in engaging GP practices across Salford, who in turn will refer suitable patients into this study. As Linda Savas, a CLAHRC GM Facilitator, notes: “Recruiting patients is a challenge, however, using the FARSITE research tool will help us to identify patients with IGR and work together with Salford GP practices to find and recruit patients.”

The final report on the findings of this work will be delivered in August 2016. For more information about our engagement of practices as part of the trial please contact Linda Savas, CLAHRC GM Facilitator.